Real-world data of the use and experience of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura: Case series.

Marta Albanell-Fernández,Inés Monge-Escartín, Esther Carcelero-San Martín, Gisela Riu Viladoms, Sonia Ruiz-Boy,Miquel Lozano,Dolors Soy,Ana Belén Moreno-Castaño,Maribel Diaz-Ricart,Joan Cid

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis（2023）

引用 1|浏览7

暂无评分

摘要

We provided real-world evidence in the treatment of aTTP, confirming the results obtained in clinical trials. Caplacizumab reduced the time to platelet count recovery and the number and length of plasma exchanges.

查看译文

关键词

Caplacizumab,Plasma exchange,Platelet count,Acquired thrombotic thrombocytopenic purpura,ADAMTS13,Real-world evidence

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要